Evidence map›Paper›PMID 38666284›Full record

ReviewThe Neurohospitalist2024

Cerebral Protection in Trans-Catheter Aortic Valve Replacement: Review and Contemporary Assessment of Randomized Trial Data.

Vivek C Mehta, Sanjay A Chandrasekhar, Donald L Quimby, Ajay Bhandari, Victoria Mazo, Alexander D Glaser, David Z Rose, Bibhu D Mohanty

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Neurohospitalist, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vivek C MehtaDivision of Cardiology, Department of Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.ORCID https://orcid.org/0000-0002-2109-9359
Sanjay A ChandrasekharDivision of Cardiology, Department of Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.ORCID https://orcid.org/0000-0002-4986-1237
Donald L QuimbyDivision of Cardiology, Department of Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.
Ajay BhandariDivision of Cardiology, Department of Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.
Victoria MazoDivision of Vascular Neurology, Department of Neurology, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.
Alexander D GlaserSection of Cardiology, Department of Internal Medicine, Louisiana State University, New Orleans, LA, USA.
David Z RoseDivision of Vascular Neurology, Department of Neurology, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.
Bibhu D MohantyDivision of Cardiology, Department of Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.
University of South Florida · USLouisiana State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the population has aged and as aortic valve therapies have evolved, the use of trans-catheter aortic valve replacement (TAVR) has grown dramatically over the past decade. A well-known complication of percutaneous cardiac intervention is embolic phenomena, and TAVR is among the highest risk procedures for clinical and subclinical stroke. As indications for TAVR expand to lower-risk and ultimately younger patients, the long-term consequences of stroke are amplified. Cerebral embolic protection (CEP) devices have taken a on unique preventative role following the Food and Drug Administration approval of the Sentinel

Indexed as

cerebral embolic protectionsilent brain infarctionstroketrans-catheter aortic valve replacement

Identifiers

PMID38666284
PMCPMC11040624
OpenAlexW4390587390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.